High positivity values for bovine leukemia virus in human breast cancer cases from Minas Gerais, Brazil

• Autor(a) principal: Emília Delarmelina
• Data de Publicação: 2020
• Outros Autores: Grazielle Cossenzo Florentino Galinari, Cristiana Buzelin Nunes, Rômulo Cerqueira Leite, Érica Azevedo Costa, Jenner Karlisson Pimenta Dos Reis, Marcelo Araújo Buzelin, Breno Samuel de Souza, Francielli Martins Souto, Juliana Marques Bicalho, Rebeca Jéssica Falcão Câmara, Cláudia Fideles Resende, Bruna Lopes Bueno, Raphael Mattoso Victor
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Repositório Institucional da UFMG
• Texto Completo: http://hdl.handle.net/1843/41159
• topic: Bovine Leukemia Virus (BLV); Human breast cancer; Minas Gerais; Brasil; Medicina; Leukemia Virus, Bovine; Breast Neoplasms

Bovine leukemia virus (BLV) is a retrovirus that causes lymphoma in cattle worldwide and has also been associated with breast cancer in humans. The mechanism of BLV infection in humans and its implication as a primary cause of cancer in women are not known yet. BLV infection in humans may be caused by the consumption of milk and milk-products or meat from infected animals. Breast cancer incidence rates in Brazil are high, corresponding to 29.5% a year of cancer cases among women. In 2020, an estimated 66,280 new cases of breast cancer are expected, whereas in 2018 breast cancer has led to 17,572 deaths, the highest incidence and lethality among cancers in women in this country that year. BLV infection occurrence ranges from 60 to 95% in dairy herds. In addition, there are some regions, such as the Minas Gerais State, southeastern Brazil, where the population traditionally consume unpasteurized dairy products. Taken together, this study aimed to verify if there is a higher association between breast cancer and the presence of BLV genome in breast tissue samples within this population that consumes raw milk from animals with high rates of BLV infection. A molecular study of two BLV genes was carried out in 88 breast parenchyma samples, between tumors and controls. The amplified fragment was subjected to BLV proviral sequencing and its identity was confirmed using GenBank. BLV proviral genes were amplified from tumor breast parenchyma samples and healthy tissue control samples from women, revealing a 95.9% (47/49) and 59% (23/39) positivity, respectively. Our results show the highest correlation of BLV and human breast cancer found in the world to date within the population of Minas Gerais, Brazil.